Background: Large language models (LLMs) are increasingly used by patients for health information and preliminary medical advice. In patient-facing consultations, users may present explicitly stated diagnostic preferences or symptom narratives emphasizing a preferred explanation. Such cognitively biased input constrains the diagnostic context available to the model and may systematically steer its reasoning during interactive LLM-supported […]
Sociodemographic Paradoxes and Enrollment Differences in In-Person Versus Online Recruitment to a Mobile Health Smoking Cessation Intervention for Food-Insecure Adults: Secondary Analysis of a Randomized Controlled Trial
Background: Little is known about (1) sociodemographic, psychosocial, or smoking-related differences among individuals recruited to smoking cessation randomized controlled trials (RCTs) using in-person versus online recruitment methods or (2) the relative speed of recruitment using these 2 approaches. This secondary analysis is the first to examine these comparisons in a smoking cessation RCT for people […]
Max-Severity Ivanti Flaw Exploited 24 Hours After Disclosure
Initial methods suggest attackers had likely mapped out Ivanti’s asset landscape upfront and acted quickly once the exploit became public.
Telerehabilitation in Community Stroke Services: Mixed Methods Evaluation of Current Practice and Lessons for Sustained Use
Background: The delivery of specialist stroke rehabilitation is undergoing a significant transformation, with telerehabilitation increasingly integrated into clinical practice and supported by guidelines and policy. There is a need for the pragmatic evaluation of telerehabilitation in service, which includes insights from clinical teams and people with stroke. This evaluation sought to address that need in […]
Development of an mHealth Intervention for Reducing Sedentary Behavior in Older Adults: Delphi Study
Background: Sedentary behavior among older adults is a major public health concern, contributing to the increased risk of chronic diseases and functional decline. With aging populations worldwide, prolonged sitting time (averaging up to 13 h/d in older adults) has been independently associated with cardiovascular disease, metabolic disorders, cognitive decline, and all-cause mortality. Mobile health (mHealth) […]
UK approves Novo Nordisk’s Wegovy pill
Novo Nordisk’s fast-growing Wegovy pill has been approved in the UK for weight loss, its first European market.
Adaptation and Validation of the Social Media Cyberbullying Victimization Scale Among Chinese College Students: Cross-Sectional Study
Background: Cyberbullying victimization is a significant risk factor for poor psychological well-being among college students. Existing tools fail to capture the distinct dimensions of victimization in social media contexts. Objective: This study aimed to adapt and validate a Social Media Cyberbullying Victimization Scale (SMCVS) and examine its associations with psychological outcomes among Chinese college students. […]
Takeda’s TYK2 drug bests BMS’s Sotyktu in psoriasis contest
New data with Takeda’s TYK2 inhibitor zasocitinib suggest it is significantly more effective than BMS’s Sotyktu in the treatment of psoriasis.
Experiences of Home-Dwelling Older Adults and Their Family Caregivers With Digital Health Services: Qualitative Study
Background: As the population ages, demand for health services among older adults and caregivers increases. Digital health services help meet this demand. However, acceptance and experiences differ between older adults and caregivers. Objective: This study aims to explore the specific experiences of home-dwelling older adults and their caregivers with digital health services, identify their willingness […]
Segmentation Works for OT If Operators Are Paying Attention
Operational technology security remains as difficult as ever, with even the best practice recommendation falling short.
Bridging the Gender Gap in Health Care Innovation: The Evolution of FemTech
Post Content
J&J adds rare disease wAIHA to Imaavy’s potential uses
Johnson & Johnson’s ‘Swiss army knife’ drug Imaavy has shown efficacy in a pivotal trial involving patients with rare autoimmune disorder wAIHA.